When should insurers cover off-label drug usage?
Butcher, L.
Managed Care 18(5): 40-42
2009
ISSN/ISBN: 1062-3388 PMID: 19526933 Document Number: 634193
Document emailed within 1 workday
Related Documents
Martin, R.M.; Wilton, L.V.; Mann, R.D.; Steventon, P.; Hilton, S.R. 1998: Unlicensed and off label drug use for paediatric patients. General practitioners prescribe SSRIs to children off label Bmj 317(7152): 204Howard, P.; Copland, J. 2013: Off-label, not off-limits: the FDA needs to create a safe harbor for off-label drug use Missouri Medicine 110(2): 106-109
Trujillo, J.M.; Logue, M.E.; Kunkel, R.; Demas, C.P. 2017: Off-label Usage of Absorbable Beads Containing Antibiotics for Prevention of Surgical Site Infections Wounds: a Compendium of Clinical Research and Practice 29(10): E84-E87
Zhang, Q.; Xu, B.; Yang, Y.-J.; Qiao, S.-B.; Zhang, R.-Y.; Zhang, J.-S.; Hu, J.; Qin, X.-W.; Chen, J.-L.; Shen, W.-F.; Gao, R.-L. 2008: Long-term efficacy and safety of Chinese made sirolimus eluting stents: results, including off label usage, from two centres over three years Chinese Medical Journal 121(17): 1670-1674
Leung, T.I.; Dumontier, M. 2015: Comparing Drug-Disease Associations in Clinical Practice Guideline Recommendations and Drug Product Label Indications Studies in Health Technology and Informatics 216: 1039
Miller, R.R. 1974: Drug surveillance and drug usage studies: what are they and how do they differ? American Journal of Hospital Pharmacy 31(5): 492-493
Dooley, A.G. 2007: Off-label drug use Medicine and Health Rhode Island 90(2): 63-65
Bavdekar, S.B.; Gogtay, N.J. 2005: Unlicensed and off-label drug use in children Journal of Postgraduate Medicine 51(4): 249-252
Bavdekar, S.B.; Gogtay, N.J. 2005: Unlicensed and off-label drug use in children Journal of Postgraduate Medicine 51(4): 249-252
Begg, N.T.; Connellan, T.J.; Leon, S. 1992: 'COVER' (cover of vaccination evaluated rapidly): 23 Communicable Disease Report. Cdr Review 2(11): R132
White, J.M.; Leon, S.; Begg, N.T. 1994: 'COVER' (cover of vaccination evaluated rapidly): 28 Communicable Disease Report. Cdr Review 4(2): R18-R19
Rane, A. 2006: Drug committees should not recommend "off label" prescriptions Lakartidningen 103(15-16): 1219
Leufkens, H.G.; Urquhart, J. 1994: Variability in patterns of drug usage Journal of Pharmacy and Pharmacology 46(Suppl 1): 433-437
Bouvenot, G.; Juillet, Y.; Saint-Pierre, A. 2019: Off-label drug use in France: recommendations of the academies of medicine and pharmacy La Revue du Praticien 69(2): 129-131
Sylvia, L.M. 1991: A departmental model for drug-usage evaluation Topics in Hospital Pharmacy Management 11(1): 46-52
Goulston, K. 1972: Drug usage in the irritable colon syndrome Medical Journal of Australia 1(22): 1126-1131
Dempsey, C.L.; Kaley, T.C.; Zenkel, J. 1993: Drug usage evaluation: clarithromycin as sequential therapy Hospital Formulary 28(12): 999-1001
Dumars, K.W. 1971: Parental drug usage: effect upon chromosomes of progeny Pediatrics 47(6): 1037-1041
Patry, R.A.; Huber, S.L.; Rice, G.; Hudson, H.D.; Godwin, H.N. 1985: Drug usage guidelines, Part 3: assessment of acceptance of the program Hospital Formulary 20(4): 464 470-4
1980: Board of trustees report I drug usage among amateur athletes Journal of the Tennessee Medical Association 73(5): 335-338